Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Docosanoids [FA04]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA04010065 4,11-diepi-11-F4c-NeuroP 3-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010066 11-epi-11-F4t-NeuroP 3-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010067 ent-11-epi-4-Ft-NeuroP 3-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010068 ent-4,11-diepi-4-Fc-NeuroP 3-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010069 ent-4,11-diepi-4-Ft-NeuroP 3-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010070 ent-11-epi-4-Fc-NeuroP 3-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010071 11-F4c-NeuroP 3-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010072 4-epi-11-F4t-NeuroP 3-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010073 4-epi-11-F4c-NeuroP 3-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010074 11-F4t-NeuroP 3-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010075 ent-13-F4t-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010076 ent-16-epi-13-F4c-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010077 ent-16-epi-13-F4t-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010078 ent-13-F4c-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010080 13,16-diepi-13-F4t-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010081 13,16-diepi-13-F4c-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010082 13-epi-13-F4t-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010088 16-epi-13-F4t-NeuroP (S,4Z,7Z,10Z,14E)-15-((1R,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010089 16-epi-13-F4c-NeuroP (S,4Z,7Z,10Z,14E)-15-((1S,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010090 13-F4t-NeuroP (S,4Z,7Z,10Z,14E)-15-((1S,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010091 ent-14-F4t-NeuroP (Z)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010092 ent-7-epi-14-F4c-NeuroP (Z)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010093 ent-7-epi-14-F4t-NeuroP (Z)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010094 ent-14-F4c-NeuroP (Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010095 ent-14-epi-14-F4t-NeuroP (Z)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010096 ent-7,14-diepi-14-F4c-NeuroP (Z)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010011 ent-4-F4t-NeuroP (R,E)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010029 ent-10-epi-7-F4t-NeuroP (R,4Z,8E)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010054 ent-10-epi-4-Fc-NeuroP (S,4Z,7Z,11E)-12-((1S,2R,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010079 13-epi-13-F4c-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010083 ent-13-epi-13-F4t-NeuroP (S,4Z,7Z,10Z,14E)-15-((1R,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010097 ent-7,14-diepi-14-F4t-NeuroP (Z)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010098 ent-14-epi-14-F4t-NeuroP (Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010099 14-epi-14-F4c-NeuroP (Z)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010100 7,14-diepi-14-F4t-NeuroP (Z)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010101 7,14-diepi-14-F4c-NeuroP (Z)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010102 14-epi-14-F4t-NeuroP (Z)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010103 14-F4c-NeuroP (Z)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010105 7-epi-14-F4c-NeuroP (Z)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010106 14-F4t-NeuroP (Z)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010107 ent-17-F4t-NeuroP (4Z,7Z)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010108 ent-10-epi-17-F4c-NeuroP (4Z,7Z)-9-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010109 ent-10-epi-17-F4t-NeuroP (4Z,7Z)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010110 ent-17-F4c-NeuroP (4Z,7Z)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010111 ent-17-epi-17-F4t-NeuroP (4Z,7Z)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010112 ent-10,17-diepi-17-F4c-NeuroP (4Z,7Z)-9-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010113 ent-10,17-diepi-17-F4t-NeuroP (4Z,7Z)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010114 ent-17-epi-17-F4t-NeuroP (4Z,7Z)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010115 17-epi-17-F4c-NeuroP (4Z,7Z)-9-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid FA 22:5;O3 C22H34O5 378.240625
LMFA04010116 10,17-diepi-17-F4t-NeuroP (4Z,7Z)-9-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid FA 22:5;O3 C22H34O5 378.240625